They observed that PD-1 inhibition triggered more severe thyroiditis with significantly elevated IL-6, whereas CTLA-4 blockade was associated with increased GM-CSF/MIP-1β and diffuse thyroid enlargement. Here, CCL4 is linked to thyroiditis.